Covid-19 virus via Columbia University
Since the first reports of a new coronavirus disease in Wuhan, China, in December 2019, COVID-19 has spread rapidly across the globe, threatening a pandemic. Now, researchers from CAS, a division of the American Chemical Society specializing in scientific information solutions, have issued a special report in ACS Central Science. In the report, they provide an overview of published scientific information on potential therapeutic agents and vaccines for the virus, with an emphasis on patents.
According to the World Health Organization, as of March 2, 2020, COVID-19 caused almost 90,000 confirmed illnesses and more than 3,000 deaths. The responsible virus, known as SARS-CoV-2, primarily attacks the lower respiratory system to cause viral pneumonia, but it may also affect the gastrointestinal system, heart, kidney, liver and central nervous system. If SARS-CoV-2 is not quickly contained, the virus could have devastating effects on people’s lives, worldwide health systems and the global economy. To assist with research efforts to discover therapies and vaccines for COVID-19, Cynthia Liu led a group of CAS scientists who analyzed the published scientific data on SARS-CoV-2 and related coronaviruses.
The researchers reviewed the rapidly growing body of journal articles related to COVID-19 and SARS-CoV-2, as well as patents having to do with human coronaviruses. From the last week of 2019 through March 1, 2020, more than 500 journal articles related to the virus were published electronically or in print, with numbers steadily increasing week-by-week. Topics included clinical manifestations, treatment regimens, viral structure and mechanisms, antiviral agents, and diagnostics. To date, more than 500 patents have been issued for vaccines and for therapeutic agents, such as antibodies, cytokines and nucleic acids, that could help prevent or treat coronavirus infections. Because SARS-CoV-2 is similar to other coronaviruses, such as SARS-CoV-1 and MERS-CoV, the researchers highlighted therapies previously explored for these other viruses that could also be applicable to SARS-CoV-2.
The authors do not acknowledge any funding sources for this study.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID-19
- Take Note! RSV infections are peaking, Covid-19 circulating at low levels, here’s what you can do
National spokesperson for the Department of Health, Foster Mohale said Covid-19 continues to circulate at low levels, while the influenza virus infections are starting to increase. “The National Institute for Communicable Diseases has a surveillance ...
- No, Brookings Institute didn't say Trump to blame for 70% of COVID-19 deaths | Fact check
A spokesperson for the Brookings Institution said she was not aware of such an estimate from the organization.
Go deeper with Google Headlines on:
COVID-19
[google_news title=”” keyword=”COVID-19″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
COVID-19 vaccine
- Ben Falconer: WA Police officer’s appeal against COVID-19 vaccine mandate dismissed by Supreme Court
A vaccine-resistant WA police officer who argued that mandating the COVID-19 inoculation was unlawful has lost his legal fight in the State’s highest court.
- Staying Updated With COVID-19 Vaccines Helps Combat Emerging Variants
New research using live SARS-CoV-2 virus reveals an updated vaccine provides a strong immune response against previous strains and emerging variants.
- Anti-vaccine website falsely claims Covid jabs behind cancer uptick
Studies show that Covid-19 shots save lives, but anti-vaccine advocates claim they have caused a huge spike in US cancer cases since the pandemic. This is false; the social media users and websites erroneously cite unverified reports of adverse events following inoculation,
- Pandemic fatigue and vaccine hesitancy continue to affect global public health, new 23-country study finds
While it found that global uptake of at least one COVID-19 vaccine dose was robust, a new survey published in Nature Medicine revealed mixed signals about the current acceptance of vaccines generally,
Go deeper with Google Headlines on:
COVID-19 vaccine
[google_news title=”” keyword=”COVID-19 vaccine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]